Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 15.62 | 10.76 | 6.31 | 2.01 |
Depreciation/ Depletion | 3.80 | 2.81 | 2.16 | 2.00 |
Deferred Taxes | 2.94 | 24.12 | 0.54 | 4.36 |
Non- Cash Items | 4.86 | 3.90 | 3.20 | 2.05 |
Changesin Working Capital | -25.01 | -34.29 | -14.10 | -6.33 |
Cashfrom Operating Activities | -0.44 | -14.41 | -2.38 | 0.17 |
Capital Expenditures | -7.64 | -9.49 | -4.27 | -1.39 |
Other Investing Cash Flow Items Total | 0.00 | 0.09 | 0.14 | - |
Cashfrom Investing Activities | -7.64 | -9.40 | -4.13 | -1.39 |
Financing Cash Flow Items | -12.97 | -8.89 | -5.66 | -5.46 |
Issuance( Retirement)of Debt Net | 18.96 | 34.07 | 13.13 | 4.74 |
Cashfrom Financing Activities | 5.99 | 25.18 | 7.47 | -0.71 |
Net Changein Cash | -2.08 | 1.36 | 0.96 | -1.93 |
Cash Interest Paid | 13.65 | 9.28 | 4.67 | 4.16 |
Issuance( Retirement)of Stock Net | - | - | - | 0.00 |
Fredun Pharmaceuticals Dividend Fredun Pharmaceuticals Bonus Fredun Pharmaceuticals News Fredun Pharmaceuticals AGM Fredun Pharmaceuticals Rights Fredun Pharmaceuticals Splits Fredun Pharmaceuticals Board Meetings Fredun Pharmaceuticals Key Metrics Fredun Pharmaceuticals Shareholdings Fredun Pharmaceuticals Profit Loss Fredun Pharmaceuticals Balance Sheet Fredun Pharmaceuticals Q1 Results Fredun Pharmaceuticals Q2 Results Fredun Pharmaceuticals Q3 Results Fredun Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks